R&D Center
The R&D center is equipped with multiple
advanced process platforms, including AAV process platform, mRNA process
platform, prokaryotic process platform, Pichia pastoris process
platform, vaccine process platform, and pre-filled syringe/cartridge
formulation platform, capable of undertaking small-scale and pilot-scale
preparation.
Service Product Categories
Protein-based
Products: Monoclonal antibodies (mAbs), bispecific
antibodies (BsAbs), Fc fusion proteins, recombinant proteins.
Viral
Vector Products: Adenovirus (Ad5/Ad26), vesicular
stomatitis virus (VSV), lentivirus (LV), adeno-associated virus
(AAV2/AAV6/AAV8).
Nucleic
Acid-based Products: mRNA.
Upstream Process Development Platform
Expression Systems: Mammalian cells systems
(CHO cells, 293 cells), microbial systems (E. coli, Pichia pastoris).
Multi-functional process development
zones designed to prevent product cross-contamination.
Diverse cultivation process
development: Fed-batch, perfusion, high-density inoculation, and more.
Upstream process characterization development.
Stainless-steel bioreactors: 5 L scale-up
(E. coli, P. pastoris).
Single-use
bioreactors: 5 L scale-up (CHO cells, 293 cells).
Downstream Process Development Platform
Capture and polishing chromatography process
development
Ultrafiltration process development
Virus removal and inactivation process
development
Process scale-up at 50–500L scale
Downstream process characterization development